Tumor size is associated with malignant potential in renal cell carcinoma cases.

Tumor size is associated with malignant potential in renal cell carcinoma cases.
复制标题

DOI:
10.1016/j.juro.2009.01.027
复制
发表时间:
2009-05
期刊:
The Journal of urology
影响因子:
--
通讯作者:
Russo P
Russo P
中科院分区:
其他
文献类型:
--
作者:
Thompson RH;Kurta JM;Kaag M;Tickoo SK;Kundu S;Katz D;Nogueira L;Reuter VE;Russo P

文献摘要

参考文献

被引文献

相似文献

我们评估了我们在肾皮质肿瘤方面的经验,以确定肿瘤大小是否与恶性组织学和/或核分级相关。我们确定了1989年至2007年期间在纪念斯隆-凯特琳医院接受手术治疗的2,675例肾细胞癌(RCC)或良性肿瘤患者。从我们的肾癌数据库中获得组织学亚型和肿瘤大小,并进行逻辑回归分析。在2,675例肿瘤中,311例(12%)为良性,2,364例(88%)为RCC。恶性肿瘤与肿瘤大小相关的比值比为1.16(95% CI 1.11 - 1.22; p <0.001),表明肿瘤大小每增加1 cm,恶性肿瘤的比值比增加16%。良性肿瘤的百分比从小于1 cm的38%下降到7 cm或更大的7%。对于透明细胞肾细胞癌患者,肿瘤大小每增加1 cm,与低级别(Fuhrman 1 - 2级)肿瘤相比,高级别(Fuhrman 3 - 4级)肿瘤的几率增加25%(比值比1.25,95% CI 1.21 - 1.30; p <0.001)。对于该亚组,高级别肿瘤的百分比从7 cm肿瘤的0%增加。<1cm to 59% for tumors >我们的研究结果证实了以前的观察结果,即恶性肿瘤的风险和高级别肿瘤的风险随着肿瘤的大小而增加。肾脏小肿块的患者发生高级别透明细胞恶性肿瘤的风险较低,这在初次会诊时可能有用。
We evaluated our experience with renal cortical tumors to determine if tumor size is associated with malignant histology and/or nuclear grade. We identified 2,675 patients treated surgically at Memorial Sloan-Kettering for renal cell carcinoma (RCC) or a benign tumor between 1989 and 2007. Histologic subtype and tumor size were obtained from our kidney cancer database and logistic regression analyses were performed. Among the 2,675 tumors, 311 (12%) were benign while 2,364 (88%) were RCC. The odds ratio for association of malignancy with tumor size was 1.16 (95% CI 1.11–1.22; p<0.001), indicating that each 1cm increase in tumor size was associated with a 16% increase in the odds of malignancy. The percentage of benign tumors decreased from 38% for those less than 1 cm to 7% for tumors 7 cm or greater. For patients with clear cell RCC, each 1 cm increase in tumor size increased the odds of a high grade (Fuhrman grade 3–4) compared with a low grade (Fuhrman grade 1–2) tumor by 25% (odds ratio 1.25, 95% CI 1.21–1.30; p<0.001). For this subset, the percentage of high grade tumors increased from 0% for tumors <1cm to 59% for tumors >7cm. Our results confirm previous observations suggesting that the risk of malignancy and risk of high grade tumors increases with tumor size. Patients with small renal masses have a low risk for harboring a high-grade clear cell malignancy which may be useful during initial consultation.
DOI: 10.1097/01.ju.0000095475.12515.5e
发表时间: 2003-12-01
期刊: JOURNAL OF UROLOGY
影响因子: 6.6
作者:
Frank, I;Blute, ML;Zincke, H
通讯作者: Zincke, H
DOI: 10.1111/j.1464-410x.2004.05165.x
发表时间: 2004-12-01
期刊: BJU INTERNATIONAL
影响因子: 4.5
作者:
Saranchuk, JW;Touijer, AK;Russo, P
通讯作者: Russo, P
DOI: 10.1016/j.juro.2007.09.077
发表时间: 2008-02-01
期刊: JOURNAL OF UROLOGY
影响因子: 6.6
作者:
Thompson, R. Houston;Boorjian, Stephen A.;Blute, Michael L.
通讯作者: Blute, Michael L.
DOI: 10.1016/s1470-2045(06)70803-8
发表时间: 2006-09-01
期刊: LANCET ONCOLOGY
影响因子: 51.1
作者:
Huang, William C.;Levey, Andrew S.;Rosso, Paul
通讯作者: Rosso, Paul
DOI: 10.1016/s1470-2045(07)70044-x
发表时间: 2007-04-01
期刊: LANCET ONCOLOGY
影响因子: 51.1
作者:
Divgi, Chaitanya R.;Pandit-Taskar, Neeta;Russo, Paul
通讯作者: Russo, Paul